Ligand Pharma (LGND) PT Raised to $162 at Oppenheimer
Tweet Send to a Friend
(Updated - July 30, 2025 6:32 AM EDT)
Oppenheimer analyst Trevor Allred raised the price target on Ligand Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Trevor Allred raised the price target on Ligand Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
